Phibro Animal Health Corporation (PAHC)

Gross profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross profit	US$ in thousands	399,942	313,092	298,237	285,400	271,377
Revenue	US$ in thousands	1,296,220	1,017,680	977,889	942,300	833,350
Gross profit margin		30.85%	30.77%	30.50%	30.29%	32.56%

June 30, 2025 calculation

Gross profit margin = Gross profit ÷ Revenue
= $399,942K ÷ $1,296,220K
= 30.85%

The gross profit margin of Phibro Animal Health Corporation exhibits a relatively stable yet gradually improving trend over the observed period from June 30, 2021, to June 30, 2025. As of June 30, 2021, the gross profit margin was 32.56%, representing the highest point in the analyzed timeframe. Subsequently, there was a decline in 2022 to 30.29%, indicating a reduction in gross profitability relative to sales.

However, from 2022 onward, the gross profit margin shows signs of recovery and stabilization, increasing modestly each year. By June 30, 2023, it reached 30.50%, which is slightly above the 2022 figure, suggesting a marginal improvement in gross profitability. This upward trend continues through June 30, 2024, with the margin reaching 30.77%. The most recent data point, as of June 30, 2025, indicates a gross profit margin of 30.85%, representing a slight increase from the previous year.

Overall, the gross profit margin demonstrates a slight decline from 2021 to 2022, followed by a gradual and steady recovery in subsequent years. The trend indicates efforts toward maintaining or improving gross profitability, although the margins remain relatively stable around the low 30% range over the latter years. This pattern suggests stability in the company's cost management relative to sales, with minor fluctuations that could be indicative of market conditions, product mix changes, or pricing strategies.